Cargando…
Testicular Cancer: Genes, Environment, Hormones
Testicular cancer (TC) represents one of the most peculiar clinical challenges at present. In fact, currently treatments are so effective ensuring a 5 years disease-free survival rate in nearly 95% of patients. On the other hand however, TC represents the most frequent newly diagnosed form of cancer...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626920/ https://www.ncbi.nlm.nih.gov/pubmed/31338064 http://dx.doi.org/10.3389/fendo.2019.00408 |
_version_ | 1783434621408509952 |
---|---|
author | De Toni, Luca Šabovic, Iva Cosci, Ilaria Ghezzi, Marco Foresta, Carlo Garolla, Andrea |
author_facet | De Toni, Luca Šabovic, Iva Cosci, Ilaria Ghezzi, Marco Foresta, Carlo Garolla, Andrea |
author_sort | De Toni, Luca |
collection | PubMed |
description | Testicular cancer (TC) represents one of the most peculiar clinical challenges at present. In fact, currently treatments are so effective ensuring a 5 years disease-free survival rate in nearly 95% of patients. On the other hand however, TC represents the most frequent newly diagnosed form of cancer in men between the ages of 14 and 44 years, with an incidence ranging from <1 to 9.9 affected individuals per 100,000 males across countries, while the overall incidence is also increasing worldwide. Furthermore, cancer survivors show a 2% risk of developing cancer in the contralateral testis within 15 years of initial diagnosis. This complex and multifaceted scenario requires a great deal of effort to understand the clinical base of available evidence. It is now clear that genetic, environmental and hormonal risk factors concur and mutually influence both the development of the disease and its prognosis, in terms of response to treatment and the risk of recurrence. In this paper, the most recent issues describing the relative contribution of the aforementioned risk factors in TC development are discussed. In addition, particular attention is paid to the exposure to environmental chemical substances and thermal stress, whose role in cancer development and progression has recently been investigated at the molecular level. |
format | Online Article Text |
id | pubmed-6626920 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66269202019-07-23 Testicular Cancer: Genes, Environment, Hormones De Toni, Luca Šabovic, Iva Cosci, Ilaria Ghezzi, Marco Foresta, Carlo Garolla, Andrea Front Endocrinol (Lausanne) Endocrinology Testicular cancer (TC) represents one of the most peculiar clinical challenges at present. In fact, currently treatments are so effective ensuring a 5 years disease-free survival rate in nearly 95% of patients. On the other hand however, TC represents the most frequent newly diagnosed form of cancer in men between the ages of 14 and 44 years, with an incidence ranging from <1 to 9.9 affected individuals per 100,000 males across countries, while the overall incidence is also increasing worldwide. Furthermore, cancer survivors show a 2% risk of developing cancer in the contralateral testis within 15 years of initial diagnosis. This complex and multifaceted scenario requires a great deal of effort to understand the clinical base of available evidence. It is now clear that genetic, environmental and hormonal risk factors concur and mutually influence both the development of the disease and its prognosis, in terms of response to treatment and the risk of recurrence. In this paper, the most recent issues describing the relative contribution of the aforementioned risk factors in TC development are discussed. In addition, particular attention is paid to the exposure to environmental chemical substances and thermal stress, whose role in cancer development and progression has recently been investigated at the molecular level. Frontiers Media S.A. 2019-07-02 /pmc/articles/PMC6626920/ /pubmed/31338064 http://dx.doi.org/10.3389/fendo.2019.00408 Text en Copyright © 2019 De Toni, Šabovic, Cosci, Ghezzi, Foresta and Garolla. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Endocrinology De Toni, Luca Šabovic, Iva Cosci, Ilaria Ghezzi, Marco Foresta, Carlo Garolla, Andrea Testicular Cancer: Genes, Environment, Hormones |
title | Testicular Cancer: Genes, Environment, Hormones |
title_full | Testicular Cancer: Genes, Environment, Hormones |
title_fullStr | Testicular Cancer: Genes, Environment, Hormones |
title_full_unstemmed | Testicular Cancer: Genes, Environment, Hormones |
title_short | Testicular Cancer: Genes, Environment, Hormones |
title_sort | testicular cancer: genes, environment, hormones |
topic | Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626920/ https://www.ncbi.nlm.nih.gov/pubmed/31338064 http://dx.doi.org/10.3389/fendo.2019.00408 |
work_keys_str_mv | AT detoniluca testicularcancergenesenvironmenthormones AT saboviciva testicularcancergenesenvironmenthormones AT cosciilaria testicularcancergenesenvironmenthormones AT ghezzimarco testicularcancergenesenvironmenthormones AT forestacarlo testicularcancergenesenvironmenthormones AT garollaandrea testicularcancergenesenvironmenthormones |